76 related articles for article (PubMed ID: 11162600)
21. Mechanisms of proteasome inhibitor PS-341-induced G(2)-M-phase arrest and apoptosis in human non-small cell lung cancer cell lines.
Ling YH; Liebes L; Jiang JD; Holland JF; Elliott PJ; Adams J; Muggia FM; Perez-Soler R
Clin Cancer Res; 2003 Mar; 9(3):1145-54. PubMed ID: 12631620
[TBL] [Abstract][Full Text] [Related]
22. Growth inhibition of gastric cancer cells by all-trans retinoic acid through arresting cell cycle progression.
Wu Q; Chen Z; Su W
Chin Med J (Engl); 2001 Sep; 114(9):958-61. PubMed ID: 11780391
[TBL] [Abstract][Full Text] [Related]
23. NS1- and minute virus of mice-induced cell cycle arrest: involvement of p53 and p21(cip1).
Op De Beeck A; Sobczak-Thepot J; Sirma H; Bourgain F; Brechot C; Caillet-Fauquet P
J Virol; 2001 Nov; 75(22):11071-8. PubMed ID: 11602746
[TBL] [Abstract][Full Text] [Related]
24. ING1 represses transcription by direct DNA binding and through effects on p53.
Kataoka H; Bonnefin P; Vieyra D; Feng X; Hara Y; Miura Y; Joh T; Nakabayashi H; Vaziri H; Harris CC; Riabowol K
Cancer Res; 2003 Sep; 63(18):5785-92. PubMed ID: 14522900
[TBL] [Abstract][Full Text] [Related]
25. PPARgamma ligands inhibit cholangiocarcinoma cell growth through p53-dependent GADD45 and p21 pathway.
Han C; Demetris AJ; Michalopoulos GK; Zhan Q; Shelhamer JH; Wu T
Hepatology; 2003 Jul; 38(1):167-77. PubMed ID: 12829999
[TBL] [Abstract][Full Text] [Related]
26. Proliferation arrest in G1 phase of a non-small cell lung cancer cell line (NSCLC-N6) treated by an original compound methyl-4-methoxy-3-(3-methyl-2-butanoyl) benzoate (VT1) independently of the p53/p21 cascade.
Jacquot C; Moreau D; Tomasoni C; Juge M; Coiffard L; Roussis V; Roussakis C
Int J Oncol; 2003 Aug; 23(2):495-501. PubMed ID: 12851701
[TBL] [Abstract][Full Text] [Related]
27. [Effects of hepatitis B virus X gene on p21(WAF1) expression through p53-dependent and p53-independent pathways].
Lin J; Zhu MH; Qu JH; Li FM; Ni CR
Ai Zheng; 2004 Jul; 23(7):749-55. PubMed ID: 15248906
[TBL] [Abstract][Full Text] [Related]
28. Novel lysine-spermine conjugate inhibits polyamine transport and inhibits cell growth when given with DFMO.
Weeks RS; Vanderwerf SM; Carlson CL; Burns MR; O'Day CL; Cai F; Devens BH; Webb HK
Exp Cell Res; 2000 Nov; 261(1):293-302. PubMed ID: 11082299
[TBL] [Abstract][Full Text] [Related]
29. Polyamine depletion inhibits apoptosis following blocking of survival pathways in human chondrocytes stimulated by tumor necrosis factor-alpha.
Stanic I; Facchini A; Borzì RM; Vitellozzi R; Stefanelli C; Goldring MB; Guarnieri C; Facchini A; Flamigni F
J Cell Physiol; 2006 Jan; 206(1):138-46. PubMed ID: 15965903
[TBL] [Abstract][Full Text] [Related]
30. Key role for p27Kip1, retinoblastoma protein Rb, and MYCN in polyamine inhibitor-induced G1 cell cycle arrest in MYCN-amplified human neuroblastoma cells.
Wallick CJ; Gamper I; Thorne M; Feith DJ; Takasaki KY; Wilson SM; Seki JA; Pegg AE; Byus CV; Bachmann AS
Oncogene; 2005 Aug; 24(36):5606-18. PubMed ID: 16007177
[TBL] [Abstract][Full Text] [Related]
31. Opposing effects of suramin and DL-alpha-difluoromethylornithine on polyamine metabolism contribute to a synergistic action on B16 melanoma cell growth in vitro.
Gritli-Linde A; Björkman U; Delle U; Hultborn R; Johansson BR; Nannmark U; Linde A
Anticancer Res; 1998; 18(2A):863-70. PubMed ID: 9615733
[TBL] [Abstract][Full Text] [Related]
32. Development of difluoromethylornithine (DFMO) as a chemoprevention agent.
Meyskens FL; Gerner EW
Clin Cancer Res; 1999 May; 5(5):945-51. PubMed ID: 10353725
[TBL] [Abstract][Full Text] [Related]
33. The gastrointestinal polyamine source depletion enhances DFMO induced polyamine depletion in MCF-7 human breast cancer cells in vivo.
Levêque J; Burtin F; Catros-Quemener V; Havouis R; Moulinoux JP
Anticancer Res; 1998; 18(4A):2663-8. PubMed ID: 9703925
[TBL] [Abstract][Full Text] [Related]
34. alpha-difluoromethylornithine induces apoptosis as well as anti-angiogenesis in the inhibition of tumor growth and metastasis in a human gastric cancer model.
Takahashi Y; Mai M; Nishioka K
Int J Cancer; 2000 Jan; 85(2):243-7. PubMed ID: 10629084
[TBL] [Abstract][Full Text] [Related]
35. D,L-alpha-difluoromethylornithine, an irreversible inhibitor of ornithine decarboxylase, induces differentiation in MEL cells.
Choudhary SK; Sharma D; Dixit A
Cell Biol Int; 1999; 23(7):489-95. PubMed ID: 10728786
[TBL] [Abstract][Full Text] [Related]
36. Polyamine depletion induces G1 and S phase arrest in human retinoblastoma Y79 cells.
Ueda A; Araie M; Kubota S
Cancer Cell Int; 2008 Jan; 8():2. PubMed ID: 18208615
[TBL] [Abstract][Full Text] [Related]
37. Synergistic antiproliferative activity of human fibroblast interferon in combination with alpha-difluoromethylornithine against human gastric cancer cells in vitro.
Kubota S
Cancer; 1992 May; 69(10):2395-9. PubMed ID: 1568161
[TBL] [Abstract][Full Text] [Related]
38. Induction of major chromosome aberrations in Chinese hamster ovary cells by alpha-difluoromethylornithine.
Pohjanpelto P; Knuutila S
Cancer Res; 1984 Oct; 44(10):4535-9. PubMed ID: 6432316
[TBL] [Abstract][Full Text] [Related]
39. JunD stabilization results in inhibition of normal intestinal epithelial cell growth through P21 after polyamine depletion.
Li L; Liu L; Rao JN; Esmaili A; Strauch ED; Bass BL; Wang JY
Gastroenterology; 2002 Sep; 123(3):764-79. PubMed ID: 12198703
[TBL] [Abstract][Full Text] [Related]
40. Schedule dependent potentiation of antitumor drug effects by alpha-difluoromethylornithine in human gastric carcinoma cells in vitro.
Barranco SC; Townsend CM; Ho BY; Reumont KJ; Koester SK; Ford PJ
Invest New Drugs; 1990; 8 Suppl 1():S9-18. PubMed ID: 1696247
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
